Premature ejaculation - current concepts in the management: A narrative review

Area of Science:

• Urology
• Andrology
• Sexual Medicine

Background:

• Premature ejaculation (PE) is a prevalent sexual dysfunction impacting 20-30% of sexually active men.
• PE manifests in four distinct types: primary, secondary, natural variable, and subjective.
• It represents a significant concern in sexual health and relationships.

Purpose of the Study:

• To provide a comprehensive review of the pathophysiology of premature ejaculation.
• To discuss the various available management strategies for PE.
• To highlight Dapoxetine as a specific pharmacological treatment for PE.

Main Methods:

• This study is a review of existing literature on premature ejaculation.
• It synthesizes information on the causes, classification, and treatment of PE.
• Focuses on both non-pharmacological and pharmacological interventions.

Main Results:

• PE is a common condition with diverse underlying mechanisms.
• Multiple treatment options exist, ranging from behavioral therapies to medications.
• Dapoxetine is a notable pharmacological agent developed for PE treatment.

Conclusions:

• Understanding PE pathophysiology is crucial for effective management.
• A combination of treatment approaches may be necessary for optimal outcomes.
• Further research into PE management continues to evolve.